Pages that link to "Q42831410"

The following pages link to Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner (Q42831410):

Displaying 43 items.

• Crystal structure of the human vascular adhesion protein-1: unique structural features with functional implications (Q24646745) (← links)
• Hepatic consequences of vascular adhesion protein-1 expression (Q28236182) (← links)
• Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases (Q28244962) (← links)
• Association between plasma activities of semicarbazide-sensitive amine oxidase and angiotensin-converting enzyme in patients with type 1 diabetes mellitus (Q28245127) (← links)
• Dysregulated hepatic expression of glucose transporters in chronic disease: contribution of semicarbazide-sensitive amine oxidase to hepatic glucose uptake (Q28250220) (← links)
• Change in vascular adhesion protein-1 and metabolic phenotypes after vertical banded gastroplasty for morbid obesity (Q28253116) (← links)
• Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes (Q28304388) (← links)
• Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease (Q28568746) (← links)
• Association between metabolically healthy central obesity in women and levels of soluble receptor for advanced glycation end products, soluble vascular adhesion protein-1, and the activity of semicarbazide-sensitive amine oxidase (Q33619918) (← links)
• Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis (Q35056710) (← links)
• Serum Vascular Adhesion Protein-1 Predicts End-Stage Renal Disease in Patients with Type 2 Diabetes (Q35914428) (← links)
• Organic cation transporter 3 contributes to norepinephrine uptake into perivascular adipose tissue. (Q36422420) (← links)
• Homing‐associated molecules CD73 and VAP‐1 as targets to prevent harmful inflammations and cancer spread (Q37868326) (← links)
• Semicarbazide-sensitive amine oxidase and kidney disease (Q38156644) (← links)
• Ectoenzymes in leukocyte migration and their therapeutic potential (Q38196724) (← links)
• Vascular adhesion protein-1: Role in human pathology and application as a biomarker (Q38569377) (← links)
• Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in lipopolysaccharide-induced pulmonary inflammation (Q38622845) (← links)
• Protective effect of the multitarget compound DPH-4 on human SSAO/VAP-1-expressing hCMEC/D3 cells under oxygen-glucose deprivation conditions: an in vitro experimental model of cerebral ischaemia. (Q38835918) (← links)
• Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1/semicarbazide-sensitive amine oxidase (sVAP-1) and cardiometabolic risk markers in apparently healthy adolescents: a cross-sectional study (Q38853305) (← links)
• New actions of an old friend: perivascular adipose tissue's adrenergic mechanisms. (Q38998472) (← links)
• Characterization of A7r5 cell line transfected in a stable form by hSSAO/VAP-1 gene (A7r5 hSSAO/VAP-1 cell line). (Q40152752) (← links)
• Inhibition of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 reduces lipopolysaccharide-induced neuroinflammation. (Q40239943) (← links)
• Crystallization of a truncated soluble human semicarbazide-sensitive amine oxidase (Q40309705) (← links)
• Vascular adhesion protein 1 in nonalcoholic steatohepatitis: a novel biomarker? (Q41558737) (← links)
• Perivascular Adipose Tissue's Impact on Norepinephrine-Induced Contraction of Mesenteric Resistance Arteries (Q41807882) (← links)
• Vascular adhesion protein-1 and renalase in regard to diabetes in hemodialysis patients. (Q42686515) (← links)
• The release of soluble VAP-1/SSAO by 3T3-L1 adipocytes is stimulated by isoproterenol and low concentrations of TNFalpha (Q42809919) (← links)
• Vascular adhesion protein‐1 and syndecan‐1 in septic shock (Q45021935) (← links)
• Influence of prolonged fasting on monoamine oxidase and semicarbazide-sensitive amine oxidase activities in rat white adipose tissue. (Q45934401) (← links)
• Serum vascular adhesion protein-1 level is higher in smokers than non-smokers. (Q46517140) (← links)
• A comparison between radiometric and fluorimetric methods for measuring SSAO activity (Q46648427) (← links)
• Influence of high-fat diet on amine oxidase activity in white adipose tissue of mice prone or resistant to diet-induced obesity. (Q46717434) (← links)
• The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease (Q46923380) (← links)
• Comparison of phenelzine and geometric isomers of its active metabolite, β-phenylethylidenehydrazine, on rat brain levels of amino acids, biogenic amine neurotransmitters and methylamine (Q48171413) (← links)
• Using gene expression to predict the secretome of differentiating human preadipocytes. (Q51815748) (← links)
• Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice. (Q53823068) (← links)
• Determination of Semicarbazide-Sensitive Amine Oxidase Activity in Blood Plasma by a Light Scattering Technique (Q58128681) (← links)
• The origin of mammalian plasma amine oxidases (Q80036264) (← links)
• Studies on the insulinomimetic effects of benzylamine, exogenous substrate of semicarbazide-sensitive amine oxidase enzyme in streptozotocin induced diabetic rats (Q80152457) (← links)
• Serum soluble vascular adhesion protein‐1 is a valuable prognostic marker in gastric cancer (Q83393733) (← links)
• New tools for studying old questions: antibodies for human diamine oxidase (Q85651451) (← links)
• Evolution and functional classification of mammalian copper amine oxidases (Q92219917) (← links)
• Attenuation of Weight Gain and Prevention of Associated Pathologies by Inhibiting SSAO (Q92635535) (← links)